Cannabis Investment Report | December 2017

U.S. Legalized Cannabis Market: Consumer Penetration Rate

25% — Path to Federal Legalization

FDA Approves Cannabis-Derived Pharmaceuticals

20% : More States Adopt Medical Cannabis Laws

More States Adopt Recreational Laws

15% FDA Routinely Approves CBD Drugs

FDA Routinely Approves THC Drugs

10% — Federal Government Legalizes Cannabis
5% -

0% -
2016 «2017 «2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030

Source: Ackrell Capital

Monthly Cannabis Spending

We estimated average monthly spending on cannabis using data provided by dispensaries in states with
recreational laws. We then assigned spending levels (low, moderate and heavy) to each age group of
eligible consumers by state. The resulting weighted averages of monthly consumer spending used in
our analysis are as follows.

U.S. Legalized Cannabis Market: Weighted Average Monthly Consumer Spending

$190
$170
$150 7 Path to Federal Legalization
$130 FDA Approves Cannabis-Derived Pharmaceuticals
More States Adopt Medical Cannabis Laws
$110 :
More States Adopt Recreational Laws
$90 1 FDA Routinely Approves CBD Drugs
FDA Routinely Approves THC Drugs
$70 _ = ——
Federal Government Legalizes Cannabis
$50

2016 «2017 «2018 )§=2019 9 2020. 2021 «2022, 2023) 2024 )9=— 2025. 2026 )3=— 2027 »3= 2028 )3=— 2029 = 2030

Source: Ackrell Capital

110 © 2017 Ackrell Capital, LLC | Member FINRA/SIPC

HOUSE_OVERSIGHT_024746
